BioXcel Therapeutics shares pop after audit of Alzheimer’s trial data By: MarketWatch October 25, 2023 at 08:44 AM EDT Audit findings support application for approval of treatment for Alzheimer's-related agitation, company says Read More >> Related Stocks: BioXcel Therapeutics, Inc. - Common Stock